Search by Drug Name or NDC
NDC 00338-1715-40 Magnesium Sulfate 4 g/100mL Details
Magnesium Sulfate 4 g/100mL
Magnesium Sulfate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
NDC | 00338-1715 |
---|---|
Product ID | 0338-1715_b5a8b04e-abe3-41fd-adb7-7f968118bf52 |
Associated GPIs | 79400010402045 |
GCN Sequence Number | 063347 |
GCN Sequence Number Description | magnesium sulfate in water PIGGYBACK 4 G/100 ML INTRAVEN |
HIC3 | C1H |
HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
GCN | 99097 |
HICL Sequence Number | 039652 |
HICL Sequence Number Description | MAGNESIUM SULFATE IN STERILE WATER |
Brand/Generic | Generic |
Proprietary Name | Magnesium Sulfate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Magnesium Sulfate Heptahydrate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 4 |
Active Ingredient Units | g/100mL |
Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
Labeler Name | Baxter Healthcare Corporation |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA211966 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1715-40 (00338171540)
NDC Package Code | 0338-1715-40 |
---|---|
Billing NDC | 00338171540 |
Package | 40 BAG in 1 CARTON (0338-1715-40) / 100 mL in 1 BAG |
Marketing Start Date | 2020-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |